Correlation Between Nurix Therapeutics and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and Foghorn Therapeutics, you can compare the effects of market volatilities on Nurix Therapeutics and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Foghorn Therapeutics.
Diversification Opportunities for Nurix Therapeutics and Foghorn Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Nurix and Foghorn is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Nurix Therapeutics and Foghorn Therapeutics
Given the investment horizon of 90 days Nurix Therapeutics is expected to under-perform the Foghorn Therapeutics. In addition to that, Nurix Therapeutics is 1.09 times more volatile than Foghorn Therapeutics. It trades about -0.19 of its total potential returns per unit of risk. Foghorn Therapeutics is currently generating about -0.01 per unit of volatility. If you would invest 811.00 in Foghorn Therapeutics on August 28, 2024 and sell it today you would lose (21.00) from holding Foghorn Therapeutics or give up 2.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Nurix Therapeutics vs. Foghorn Therapeutics
Performance |
| Timeline |
| Nurix Therapeutics |
| Foghorn Therapeutics |
Nurix Therapeutics and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nurix Therapeutics and Foghorn Therapeutics
The main advantage of trading using opposite Nurix Therapeutics and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |